✦ LIBER ✦

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

✍ Scribed by Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Marta López-Brea; Daniel Castellano; Belén Martí; Silvia Díaz Cerezo

Book ID: 107597883
Publisher: Springer Milan
Year: 2011
Tongue: Spanish
Weight: 451 KB
Volume: 13
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-011-0748-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of continuous once-daily

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma

✍ Carlos H. Barrios; David Hernandez-Barajas; Michael P. Brown; Se-Hoon Lee; Luis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 855 KB

Cost-effectiveness projections of oxalip

Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma

✍ Bruce E. Hillner; Deborah Schrag; Daniel J. Sargent; Charles S. Fuchs; Richard M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB